Cancer remains a significant global health challenge, with chronic inflammation often contributing in tumor development and progression. , Therefore, the search for novel anti-inflammatory agents to complement conventional cancer therapies is vital. Triiptolide, a synthetic derivative of the natu

Barzolvolimab: A Novel Possibility for Autoimmune Conditions? Barzolvolimab, a recently identified therapeutic agent, is sparking substantial interest within the medical field. This unique protein functions as a potent reducer of interleukin- 17, F, a vital mediator in the pathogenes